BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20920571)

  • 21. Protein kinase C as a peripheral biomarker for Alzheimer's disease.
    de Barry J; Liégeois CM; Janoshazi A
    Exp Gerontol; 2010 Jan; 45(1):64-9. PubMed ID: 19895879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study.
    Michel TM; Gsell W; Käsbauer L; Tatschner T; Sheldrick AJ; Neuner I; Schneider F; Grünblatt E; Riederer P
    J Alzheimers Dis; 2010; 19(4):1295-301. PubMed ID: 20061610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
    Lovell MA; Markesbery WR
    J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neurobiology of isoprostanes and Alzheimer's disease.
    Praticò D
    Biochim Biophys Acta; 2010 Aug; 1801(8):930-3. PubMed ID: 20116452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
    Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
    Free Radic Res; 2008 Feb; 42(2):162-70. PubMed ID: 18297609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
    Praticò D; Clark CM; Lee VM; Trojanowski JQ; Rokach J; FitzGerald GA
    Ann Neurol; 2000 Nov; 48(5):809-12. PubMed ID: 11079549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential role of acrolein in neurodegeneration and in Alzheimer's disease.
    Dang TN; Arseneault M; Murthy V; Ramassamy C
    Curr Mol Pharmacol; 2010 Jun; 3(2):66-78. PubMed ID: 20302565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current strategies in the discovery of small-molecule biomarkers for Alzheimer's disease.
    Whiley L; Legido-Quigley C
    Bioanalysis; 2011 May; 3(10):1121-42. PubMed ID: 21585307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.
    Marcus DL; Thomas C; Rodriguez C; Simberkoff K; Tsai JS; Strafaci JA; Freedman ML
    Exp Neurol; 1998 Mar; 150(1):40-4. PubMed ID: 9514828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
    Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia induces free radical damage to rat erythrocytes and spleen: analysis of the fluorescent end-products of lipid peroxidation.
    Wilhelm J; Herget J
    Int J Biochem Cell Biol; 1999 Jun; 31(6):671-81. PubMed ID: 10404640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the composition of fatty acids and lipofuscin-like pigments during development of rat heart.
    Wilhelm J; Ivica J; Veselská Z; Uhlík J; Vajner L
    Physiol Res; 2015; 64(5):643-51. PubMed ID: 25804102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Oxidative Stress and Altered Cholesterol Metabolism in Alzheimer's Disease Patients.
    Zarrouk A; Hammouda S; Ghzaiel I; Hammami S; Khamlaoui W; Ahmed SH; Lizard G; Hammami M
    Curr Alzheimer Res; 2020; 17(9):823-834. PubMed ID: 33272182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of lutein in red blood cells of Alzheimer's disease patients.
    Kiko T; Nakagawa K; Tsuduki T; Suzuki T; Arai H; Miyazawa T
    J Alzheimers Dis; 2012; 28(3):593-600. PubMed ID: 22045492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.
    Markesbery WR; Lovell MA
    Neurobiol Aging; 1998; 19(1):33-6. PubMed ID: 9562500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipophilic fluorescent products of free radicals.
    Ivica J; Wilhelm J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):365-72. PubMed ID: 23446206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypercapnia protects erythrocytes against free radical damage induced by hypoxia in exposed rats.
    Skoumalová A; Herget J; Wilhelm J
    Cell Biochem Funct; 2008 Oct; 26(7):801-7. PubMed ID: 18683905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease.
    Praticò D; Sung S
    J Alzheimers Dis; 2004 Apr; 6(2):171-5. PubMed ID: 15096701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood markers of oxidative stress in Alzheimer's disease.
    Skoumalová A; Hort J
    J Cell Mol Med; 2012 Oct; 16(10):2291-300. PubMed ID: 22564475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers.
    Peña-Bautista C; Baquero M; Vento M; Cháfer-Pericás C
    Clin Chim Acta; 2019 Apr; 491():85-90. PubMed ID: 30685358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.